This is a past event. Registration is closed. View other NewYorkBIO events.
Welcome Remarks
Jennifer Hawks Bland•Hans Christinger

Opening remarks from NewYorkBIO's CEO, Jennifer Hawks Bland

  • Jennifer Hawks Bland (Chief Executive Officer at NewYorkBIO)

    Jennifer Hawks Bland

    Chief Executive Officer at NewYorkBIO
  • Hans Christinger (CBO at Neurvati Neurosciences)

    Hans Christinger

    CBO at Neurvati Neurosciences
Vision Talk
Cecilia Kushner•Susan Rosenthal

Remarks regarding tech-forward life science in New York City.

Sponsored by NYC EDC

  • Cecilia Kushner (Executive Vice President and Chief Strategy Office at NYC EDC)

    Cecilia Kushner

    Executive Vice President and Chief Strategy Office at NYC EDC
  • Susan Rosenthal (SVP, Life Sciences at NYCEDC)

    Susan Rosenthal

    SVP, Life Sciences at NYCEDC
General Session: Policy
Christopher Cox•Ashira Vantrees•Dr. David Jakubowicz

Do physicians or insurers decide which medicine is best for a patient? For years, insurers have employed utilization management tools that limit patient access to new therapeutics to control costs with the result of keeping many innovative treatments from patients who do not have resources to go outside insurance coverage for the best and most appropriate care. This panel will discuss the use of step therapy by payers and how it can undermine the doctor/patient relationship and what policies need to change to put the physician and patient back in the driver’s seat of their care.

  • Christopher Cox (Chief of Staff at Office of Rep. Yvette Clark)

    Christopher Cox

    Chief of Staff at Office of Rep. Yvette Clark
  • Ashira Vantrees (Counsel at Aimed Alliance)

    Ashira Vantrees

    Counsel at Aimed Alliance
  • Dr. David Jakubowicz (Elected Vice President at Medical Society of the State of New York)

    Dr. David Jakubowicz

    Elected Vice President at Medical Society of the State of New York
Vision Talk: The future of rare disease research and development
Michele Oshman•Dmitri Siegel

A TED style talk given by an industry professional.

Sponsored by BIO

  • Michele Oshman (Vice President, External Affairs; Executive Director, Council of State Bioscience Associations at Biotechnology Innovation Organization)

    Michele Oshman

    Vice President, External Affairs; Executive Director, Council of State Bioscience Associations at Biotechnology Innovation Organization
  • Dmitri Siegel (Director, State Government Affairs, Alliance Development of Bristol Myers Squibb (BMS))

    Dmitri Siegel

    Director, State Government Affairs, Alliance Development of Bristol Myers Squibb (BMS)
Networking Break
Vision Talk: Navigating the post-pandemic life science landscape
Dennis Barger•Brett Sematore

How will we successfully navigate the post-pandemic life science business landscape? If you could find the reset button, would you use it? 2020-2023 has brought both pain and profound acceleration, fundamentally transforming the way we work. Dennis will touch upon the challenges and accelerators that affect the current state of the industry, reflect on these pivotal influences, and share his thoughts on what they means for the immediate future.

Sponsored by Eppendorf

  • Dennis Barger (President at Eppendorf)

    Dennis Barger

    President at Eppendorf
  • Brett Sematore (Director of Sales for the NYC & New England Zone at Eppendorf)

    Brett Sematore

    Director of Sales for the NYC & New England Zone at Eppendorf
Panel Discussion: The Impact of New Uses for Artificial Intelligence on Product and Device Development
Nick Hardy•Linda Malek•Prem Premsrirut•Dhruv Sud•Alyssa Fronk

The proliferation of AI technology has created both exciting opportunities for product and device development as well as increased scrutiny by federal agencies of how these technologies will be built and used. In this panel, we will discuss the ways in which AI can promote new avenues of treatment through advances in product and device development. Generative AI, in particular, has the potential to revolutionize product and device development by shortening the design timeframe, and to create efficiencies in clinical trials for devices by using algorithms to collect patient data more efficiently. We will also discuss the importance of ensuring elimination of bias in data collection to promote reliable algorithms and will outline lessons learned as well as upcoming challenges and opportunities in the use of AI.

Sponsored by Moses Singer

  • Nick Hardy (Vice President of Data at Ro)

    Nick Hardy

    Vice President of Data at Ro
  • Linda Malek (Partner at Moses Singer)

    Linda Malek

    Partner at Moses Singer
  • Prem Premsrirut (CEO of Mirimus Inc)

    Prem Premsrirut

    CEO of Mirimus Inc
  • Dhruv Sud (Director, Patent Attorney of Regeneron Pharmaceuticals, Inc.)

    Dhruv Sud

    Director, Patent Attorney of Regeneron Pharmaceuticals, Inc.
  • Alyssa Fronk (Associate Director of Computational Biology at Envisagenics, Inc.)

    Alyssa Fronk

    Associate Director of Computational Biology at Envisagenics, Inc.
Lunch
Vision Talk: Cardiovascular Health Disparities in Minority Populations
Dr. Chirayu Parikh•Dan D’Angelo

After a decades long decline, deaths from cardiovascular disease (CVD) are once again on the rise and today, CVD is leading cause of death in the United States. And that rate is even higher amongst certain populations – including women, racial minorities, and rural populations. This session will provide critical background and context on the challenges before us; its impact on families, communities, and state economies across our country; and policy changes that could help to finally curb our current trajectory and improve the lives of the 30 million patients currently diagnosed with heart disease.

Sponsored by Novartis

  • Dr. Chirayu Parikh (Associate Director, Medical Science Liaison, CVM (Cardiovascular Metabolism) of Novartis)

    Dr. Chirayu Parikh

    Associate Director, Medical Science Liaison, CVM (Cardiovascular Metabolism) of Novartis
  • Dan D’Angelo (Regional Director CV Field Medical of Novartis)

    Dan D’Angelo

    Regional Director CV Field Medical of Novartis
Panel Discussion: The Future of Vaccines: New Developments and How to Tackle Vaccine Hesitancy
Dr. Amesh Adalja•Matthew Badalucco•Joe Smyser•Bethsy Morales-Reid

This panel will take the lessons learned from COVID vaccine development and the accompanying medical, political and community conversations to discuss the horizon for vaccines.

Sponsored by Merck

  • Dr. Amesh Adalja (Senior Scholar at Johns Hopkins Center for Health Security)

    Dr. Amesh Adalja

    Senior Scholar at Johns Hopkins Center for Health Security
  • Matthew Badalucco (Executive Director - East Merck State Government Affairs and Policy of Merck)

    Matthew Badalucco

    Executive Director - East Merck State Government Affairs and Policy of Merck
  • Joe Smyser (CEO of Public Good Projects)

    Joe Smyser

    CEO of Public Good Projects
  • Bethsy Morales-Reid (Vice President for Program Impact & Strategy at Hispanic Federation)

    Bethsy Morales-Reid

    Vice President for Program Impact & Strategy at Hispanic Federation
Break
Vision Talk: Fueling Innovation—What Does it Take?
Harold Hess•John Pennett

Funding is fuel for innovation. What’s the investment outlook for biotech companies based on the current funding environment—and what can you do to improve your opportunities? Learn what it means to be “diligence ready” so you and your company are positioned for success.

Sponsored by EisnerAmper

  • Harold Hess (Partner at EisnerAmper LLP)

    Harold Hess

    Partner at EisnerAmper LLP
  • John Pennett (Partner at EisnerAmper LLP)

    John Pennett

    Partner at EisnerAmper LLP
Panel Discussion: Best Practices for Talking to Investors
Sara Michelmore•Dennis Purcell•Dr. Misti Ushio•Dr. Anna Kazanchyan

Whether it’s the first-time raising capital or you’re ready to go public, connecting with investors in way that resonates can be the difference between moving your pipeline forward or shutting your doors, particularly in today’s unpredictable market. MacDougall’s Sara Michelmore will sit down with panelists to hear more about what is required to secure your next round of funding.

Sponsored by MacDougall

  • Sara Michelmore (Managing Director, Investor Relations of MacDougall Advisors)

    Sara Michelmore

    Managing Director, Investor Relations of MacDougall Advisors
  • Dennis Purcell (founder of aisling capital)

    Dennis Purcell

    founder of aisling capital
  • Dr. Misti Ushio (Managing Partner at Digitalis Ventures)

    Dr. Misti Ushio

    Managing Partner at Digitalis Ventures
  • Dr. Anna Kazanchyan (CEO and Founder of Saghmos Therapeutics)

    Dr. Anna Kazanchyan

    CEO and Founder of Saghmos Therapeutics
Break
Vision Talk: The Potential of Gene Therapy • Preparing the Policy Environment to Ensure Access for Patients.
Holly Blair•Alison Hoke
  • Holly Blair (Alliance Development at Pfizer)

    Holly Blair

    Alliance Development at Pfizer
  • Alison Hoke (Pharmacist at Kinney Drugs)

    Alison Hoke

    Pharmacist at Kinney Drugs
General Session: Energizing New York City's Life Science Ecosystem
Johanna Grossman•Susan Rosenthal•Tingting Zhang-Kharas•Bill Harvey

Energizing New York City's Life Science Ecosystem

Sponsored by JLABS

  • Johanna Grossman (Healthcare & Life Science Capital Markets at NYSE)

    Johanna Grossman

    Healthcare & Life Science Capital Markets at NYSE
  • Susan Rosenthal (SVP, Life Sciences at NYCEDC)

    Susan Rosenthal

    SVP, Life Sciences at NYCEDC
  • Tingting Zhang-Kharas (Head of johnson and johnson innovation jlabs northeast at Johnson & Johnson Innovation (JLABS))

    Tingting Zhang-Kharas

    Head of johnson and johnson innovation jlabs northeast at Johnson & Johnson Innovation (JLABS)
  • Bill Harvey (Executive Vice President at JLL)

    Bill Harvey

    Executive Vice President at JLL
Closing Remarks
Jennifer Hawks Bland
  • Jennifer Hawks Bland (Chief Executive Officer at NewYorkBIO)

    Jennifer Hawks Bland

    Chief Executive Officer at NewYorkBIO
Reception